Avoiding mistakes in a 510(k) submission is less about fixing problems later and more about building a strong regulatory strategy from the beginning. The U.S. Food and Drug Administration clears...

Introduction Bringing a medical device to the United States market through the 510(k) pathway is a critical regulatory milestone. While the process is well established, many manufacturers experience...

Introduction Bringing a medical device to the U.S. market requires clearance from the FDA, and for most Class II devices, the primary pathway is the 510(k) premarket notification. Understanding the...

Introduction: The transition from the Medical Device Directive (MDD) to the European Union Medical Device Regulation (EU MDR) marked one of the most significant regulatory shifts in the medical device...

Introduction For medical device manufacturers selling in the United States, compliance with FDA’s Quality System Regulation (QSR) under 21 CFR Part 820 is not optional — it is a legal and operational...

Introduction One of the most common questions manufacturers ask under EU MDR is deceptively simple:If we already have a Post-Market Surveillance (PMS) system, do we really need Post-Market Clinical...

Introduction: Entering global markets is no longer just about innovation—it is about regulatory intelligence. Two of the most influential regulatory frameworks governing medical devices worldwide are...

Introduction One of the most common—and costly—mistakes in medical device regulatory submissions is the misapplication of electrical safety standards. Manufacturers often ask:Should my device comply...

Introduction In medical device regulation, safety is often associated with materials, electrical performance, or clinical evidence. However, regulatory experience shows that a significant number of...